{"id":"W4409334831","doi":"10.1183/13993003.02435-2024","title":"Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for <i>F508del</i> and a minimal function mutation: results from a 96-week open-label extension study","year":2025,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Vertex Pharmaceuticals","keywords":"Medicine; Ivacaftor; Tolerability; Placebo; Cystic fibrosis; Abdominal pain; Adverse effect; Vomiting; Internal medicine; Gastroenterology; Pediatrics; Upper respiratory tract infection; Cystic fibrosis transmembrane conductance regulator; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002642604,0.000797586,0.001707898,0.0003336819,0.0002778648,0.000508126,0.0005435777,0.0008574047,0.001546443],"category_scores_gemma":[0.001508014,0.0003666825,0.001318019,0.0003359147,0.0006540951,0.0008000477,0.0003408536,0.001397014,0.0003874032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004481248,"about_ca_system_score_gemma":0.0007431145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139339,"about_ca_topic_score_gemma":0.002604457,"domain_scores_codex":[0.9990247,0.0004522062,0.00009962787,0.0001616156,0.0001284619,0.0001332252],"domain_scores_gemma":[0.9986797,0.0003129113,0.0003370477,0.00008946711,0.0001209615,0.0004599539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.755403,0.04325701,0.05485689,0.001064482,0.001389992,0.0008430419,0.0008185846,0.0009683058,0.04249603,0.00007508421,0.001422131,0.09740549],"study_design_scores_gemma":[0.3015551,0.5227122,0.165496,0.0001125115,0.001041563,0.001073334,0.000204218,0.0004130563,0.004517751,0.0000565109,0.002769346,0.0000484155],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978836,0.001084271,0.00009757133,0.0000586744,0.0000159981,0.0003027938,0.0003813702,0.00001236406,0.0001634109],"genre_scores_gemma":[0.9958197,0.001258633,0.0006770536,0.0001884047,0.00006525103,0.0005528841,0.000974726,0.000009570133,0.0004537235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002642604,"threshold_uncertainty_score":0.01397556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03588810909028672,"score_gpt":0.3160542510231996,"score_spread":0.2801661419329129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}